Алон Хершко

Научные публикации

• Oxycodone-Acetaminophen Abuse by Inhalation
• Effect of the Israel-Hamas war on allergy and immunology care and research
• Administration of BNT162b2 mRNA COVID-19 vaccine to subjects with various allergic backgrounds
• Fast Acting, Dry Powder, Needle-Free, Intranasal Epinephrine Spray: A Promising Future Treatment for Anaphylaxis
• Neutrophil-erythrocyte rosette formation: case report and proposed mechanism
• Reporting of Allergic Reactions During Pfizer-BioNTech BNTT162B2 Vaccination in Israel
• Clinical impact of allergy and pre-medication in CT studies with low-osmolality intravenous iodinated contrast media
• Severe eosinophilia in hospitalized patients
• The efficacy of off-label IL-5-modulating treatment in rare eosinophil-mediated diseases
• Allergic-like disorders and asthma in patients with common variable immunodeficiency: a multi-center experience
• Epidemiological, clinical and economic burden of severe eosinophilic asthma in Taiwan: Results from a large tertiary care hospital
• Iodinated contrast media allergy is rare in patients undergoing sialography
• A Novel Tool for Nasal Polyp Investigation: An Ex vivo Organ Culture System
• The association between anaphylaxis and post-traumatic stress disorder in subjects with Hymenoptera venom allergy
• Hymenoptera venom allergy in a single-center Israeli cohort: Clinical and laboratory characteristics
• Mean platelet volume and clinical outcomes of patients with chest pain discharged from internal medicine wards
• Characterization of chronic urticaria and associated conditions in a large population of adolescents
• Eosinophilic pneumonia following occupational smoke exposure
• A practical approach to infarction of the spleen as a rare manifestation of multiple common diseases
• Physical Training in a Medical Fitness Room for Patients with Chronic Diseases: Functional and Metabolic Outcomes
• Iodinated Contrast Media Allergy in Patients Hospitalized for Investigation of Chest Pain
• Impaired renal function is associated with adverse outcomes in patients with chest pain discharged from internal medicine wards
• IL-33 and IgE stimulate mast cell production of IL-2 and regulatory T cell expansion in allergic dermatitis
• MicroRNA-4443 regulates mast cell activation by T cell-derived microvesicles
• Insights into the mast cell-microbiome connection in the skin
• The Involvement of Protein Kinase D in T Cell-Induced Mast Cell Activation
• Seasonal Exacerbation of Asthma Is Frequently Associated with Recurrent Episodes of Acute Urticaria
• Increased Prevalence of Diabetes Mellitus in a Non-Obese Adult Population: HIV-Infected Ethiopians
• Colchicine-clarithromycin-induced rhabdomyolysis in Familial Mediterranean Fever patients under treatment for Helicobacter pylori
• CD300f associates with IL-4 receptor α and amplifies IL-4-induced immune cell responses
• Integrating innate and adaptive immune cells: Mast cells as crossroads between regulatory and effector B and T cells
• Factor IX oligomerization underlies reduced activity upon disruption of physiological conditions
• Progressive multifocal leukoencephalopathy in an HIV-negative patient following treatment with rituximab
• CMRF35-like molecule 1 (CLM-1) regulates eosinophil homeostasis by suppressing cellular chemotaxis
• T cell-derived microvesicles induce mast cell production of IL-24: relevance to inflammatory skin diseases
• Extracorporeal immunoadsorption of antibodies against the VRT-101 laminin epitope in systemic lupus erythematosus: a feasibility evaluation study
• Cyclosporin A impairs the secretion and activity of ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 repeat)
• T cell-mediated modulation of mast cell function: heterotypic adhesion-induced stimulatory or inhibitory effects
• Increased eosinophilic responses in splenectomized patients
• Cutting edge: persistence of increased mast cell numbers in tissues links dermatitis to enhanced airway disease in a mouse model of atopy
• Mast cells as sources and targets of membrane vesicles
• Rituximab induces resolution of recurrent diffuse alveolar hemorrhage in a patient with primary antiphospholipid antibody syndrome
• Mast cell interleukin-2 production contributes to suppression of chronic allergic dermatitis
• Mast cell and T cell communication; amplification and control of adaptive immunity
• Mesalamine-induced multiple pulmonary cavitary nodules associated with cytoplasmic antineutrophil cytoplasmic antibody (c-ANCA)
• Increased intracranial pressure related to systemic lupus erythematosus: a 26-year experience
• The MEFV E148Q allele: a deleterious mutation or harmless variation?
• Autoimmunity in the era of genomics and proteomics
• Removal of pathogenic autoantibodies by immunoadsorption
• Reproduction and ulcerative colitis: a review
• Susceptibility and resistance to experimental adjuvant arthritis
• Clinical and radiographic features mimicking pulmonary embolism as the first manifestation of Takayasu's arteritis
• Characterization of the human Snrpn minimal promoter and cis elements within it
• Methylation of HoxA5 and HoxB5 and its relevance to expression during mouse development
• Herpes simplex virus infection in a hyper-IgE patient: appearance of unusual mass lesions
• The mouse Snrpn minimal promoter and its human orthologue: activity and imprinting
• Constitutive hyperhistaminaemia: a possible mechanism for recurrent anaphylaxis
• The imprinting box of the Prader-Willi/Angelman syndrome domain